![Rebecca Critchley-Thorne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rebecca Critchley-Thorne
Fondateur chez Cernostics, Inc.
Profil
Rebecca Critchley-Thorne is the founder and holds the title of Vice President-Research & Development at Cernostics, Inc. which is founded in 2008.
She also worked as a Senior Scientist at Acelerate, Inc. Dr. Critchley-Thorne earned a doctorate degree from Imperial College London.
Postes actifs de Rebecca Critchley-Thorne
Sociétés | Poste | Début |
---|---|---|
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Fondateur | 01/01/2008 |
Anciens postes connus de Rebecca Critchley-Thorne
Sociétés | Poste | Fin |
---|---|---|
Acelerate, Inc.
![]() Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Directeur Technique/Scientifique/R&D | - |
Formation de Rebecca Critchley-Thorne
Imperial College London | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
Acelerate, Inc.
![]() Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |